ctrl K

Watchlist Price Alert

Maze Therapeutics Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

12.87

-0.47 (-3.52%)

At close: Jun 06, 2025, 3:59 PM

12.59

-2.18%

After-hours: Jun 06, 2025, 05:57 PM EDT

Maze Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q4 2023	Q3 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Dec 31, 2023	Sep 30, 2023
Revenue	n/a	n/a	2.5M	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	2.5M	n/a	n/a
Operating Income	-35.4M	-29.73M	-24.23M	-23.05M	-25.23M
Interest Income	n/a	1.52M	1.85M	304K	481K
Pretax Income	n/a	-29.85M	-25.03M	-26.58M	-24.75M
Net Income	n/a	-29.58M	-24.75M	-26.58M	-24.75M
Selling & General & Admin	7.82M	7.51M	6.87M	7.01M	5.77M
Research & Development	27.58M	22.22M	19.86M	16.05M	19.46M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	35.4M	29.73M	26.73M	23.05M	25.23M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	29.73M	26.73M	23.05M	25.23M
Income Tax Expense	n/a	-275K	-279K	n/a	n/a
Shares Outstanding (Basic)	28.63M	43.78M	34.97M	34.97M	34.97M
Shares Outstanding (Diluted)	28.63M	43.78M	34.97M	34.97M	34.97M
EPS (Basic)	-1.15	-1.02	-0.04	-0.76	-0.71
EPS (Diluted)	-1.15	-1.02	-0.04	-0.76	-0.71
EBITDA	-35.4M	-29.02M	-23.44M	-22.07M	-24.22M
EBIT	n/a	-29.73M	-24.23M	-23.05M	-25.23M
Depreciation & Amortization	n/a	705K	788K	976K	1M